Pembrolizumab
Keytruda
Near Add Your Location
Accepting patients
Pembrolizumab, Decitabine +/- Venetoclax
Phase 1b Study of Pembrolizumab, Decitabine +/- Venetoclax Combination Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
- BCL-2 Inhibitor
- Hypomethylating Agents (HMA)
- Monoclonal Antibody
- Phase 1